Feb 7, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Trend to Acquire and Use Digital Pathology Technology is Still in Earliest Stages
Anatomic pathology laboratories continue to purchase and deploy digital pathology systems at a brisk rate. It is confirmation that ever more pathologists are ready to adopt and use digital pathology systems.
Evidence in support of the digital pathology trend comes from a recent press release by one of the leading firms in this field. On December 15, 2010, Aperio Technologies, Inc. announced that it now has more than 700 digital pathology systems operating in 30 countries.
(more…)
Aug 24, 2010 | Laboratory News, Laboratory Pathology
Hefty purchase price sends message to pathologists and clinical laboratory executives
For any pathologist still harboring doubts about the future of digital pathology, yesterday’s surprise news that Roche Holding AG (VTX:ROG.VX) will pay $100 million to acquire BioImagene, Inc., provides compelling evidence that the digital pathology marketplace is ready for prime time.
Roche announced that it will pay $100 million to buy privately-held BioImagene of Sunnyvale, California. The purchase will be handled by Roche’s Ventana Medical Systems, Inc., and the deal is expected to close in just a few weeks. After the acquisition, BioImagene will operate as part of Ventana. BioImagene has emerged as one of the early leaders in selling digital scanners and digital pathology systems.
(more…)
Apr 16, 2010 | Instruments & Equipment, Laboratory Pathology
Leica Microsystem acquires Genetix while Omnyx licenses patents from Olympus
More pathology laboratories are acquiring and deploying digital scanners and digital pathology systems. In response to the growing demand for digital pathology solutions, several prominent companies are extending their capabilities in virtual microscope slide technology. Over recent months, an acquisition and a licensing deal provide examples of the intense activity in the digital pathology marketplace.
The acquisition was done by Leica Microsystem, Inc., of Wetzlar, Germany. On March 10th, it announced its acquisition of Genetix, Ltd., based in New Milton, UK. The licensing deal involved Omnyx, LLC, of Pittsburgh, Pennsylvania, in an agreement that gives it access to certain patents held by Olympus Corporation. Both of these transactions occurred in March. Each was motivated by initiating the company’s need to further develop its technologies in support of whole slide imaging (WSI) and digital pathology systems.
(more…)
Apr 12, 2010 | Laboratory Pathology, Management & Operations, News From Dark Daily
Pathologists and clinical lab executives will hear perspectives from 80 speakers at the upcoming Executive War College on Lab and Pathology Management
For any pathologist or clinical laboratory executive interested in the future of the lab testing industry, there will be plenty of insights at the upcoming 15th Annual Executive War College on Laboratory and Pathology Management April 27-28 at the New Orleans Sheraton Hotel. Leading a line-up of 80 speakers are David King, CEO of Laboratory Corporation of America (NYSE: LH) and Thomas Grogan, M.D., Founder and Chief Scientific Advisor of Roche Ventana Medical Systems.
There’s lots of optimism about the future of laboratory testing. That’s because genetic and molecular testing is giving pathologists new tools to more precisely diagnose disease and determine appropriate therapies. LabCorp’s David King, will speak to how lab test data is the linchpin in the drive to more tightly integrate clinical care in ways to lift patient outcomes.
(more…)
Oct 16, 2009 | Instruments & Equipment, Laboratory Pathology
Are digital whole slide imaging systems ready to replace conventional light microscopy for diagnostic surgical pathology?
Next week, an FDA committee will consider whether to allow pathologists to use digital pathology systems for primary diagnosis. Even if the committee does not make a positive recommendation, the timing demonstrates the swift progress in the quality of digital pathology images and the systems that present them to the pathologists.
Digital pathology imaging systems are slowly replacing microscopes in the nation’s clinical labs. There is now enough momentum in the market for digital pathology imaging that the FDA’s Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee will meet October 22 and 23 in Gaithersburg, Maryland, to hear from experts in digital imaging. (See agenda) The FDA review committee may later make recommendations on the public health issues related to the use of digital whole slide imaging systems to replace conventional light microscopy for diagnostic surgical pathology.
(more…)
